Che Connon
Chief Executive Officer bei BSF ENTERPRISE PLC
Vermögen: 963 522 $ am 31.03.2024
Profil
Che John Connon is the founder of Atelerix Ltd.
(founded in 2017) where he holds the title of Director.
He is also the founder of CellRev (founded in 2018) where he holds the title of Chief Technical Officer & Director.
Additionally, he is the founder of 3D Bio-Tissues Ltd.
(founded in 2019) where he holds the title of Chief Executive Officer & Director.
Currently, Dr. Connon is the Chief Executive Officer, MD & Director at BSF Enterprise Plc and a Professor-Tissue Engineering at Newcastle University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
BSF ENTERPRISE PLC
12,51% | 30.09.2023 | 12 927 977 ( 12,51% ) | 963 522 $ | 31.03.2024 |
Aktive Positionen von Che Connon
Unternehmen | Position | Beginn |
---|---|---|
BSF ENTERPRISE PLC | Chief Executive Officer | - |
Atelerix Ltd.
Atelerix Ltd. Electronic Equipment/InstrumentsElectronic Technology Atelerix Ltd. engages in preserving the viability and functionality of cells at hypothermic temperatures. The company was founded on June 5, 2017 and is headquartered in Cambridge, the United Kingdom. | Founder | 05.06.2017 |
3D Bio-Tissues Ltd.
3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The private company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Founder | 01.01.2019 |
CellRev
CellRev Miscellaneous Commercial ServicesCommercial Services CellRev is a bioprocessing British technology company that specializes in developing innovative cell expansion technology to continuously grow, detach, and collect adherent cells. The company is based in Newcastle-upon-Tyne, UK and was founded in 2018 by Che John Connon, Leo Cornelis Groenewegen, and Martina Miotto. The company's technology is used to advance lifesaving treatments and develop a new sustainable food system. | Founder | 18.12.2018 |
Newcastle University | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BSF ENTERPRISE PLC | Finance |
Private Unternehmen | 3 |
---|---|
Atelerix Ltd.
Atelerix Ltd. Electronic Equipment/InstrumentsElectronic Technology Atelerix Ltd. engages in preserving the viability and functionality of cells at hypothermic temperatures. The company was founded on June 5, 2017 and is headquartered in Cambridge, the United Kingdom. | Electronic Technology |
CellRev
CellRev Miscellaneous Commercial ServicesCommercial Services CellRev is a bioprocessing British technology company that specializes in developing innovative cell expansion technology to continuously grow, detach, and collect adherent cells. The company is based in Newcastle-upon-Tyne, UK and was founded in 2018 by Che John Connon, Leo Cornelis Groenewegen, and Martina Miotto. The company's technology is used to advance lifesaving treatments and develop a new sustainable food system. | Commercial Services |
3D Bio-Tissues Ltd.
3D Bio-Tissues Ltd. BiotechnologyHealth Technology Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The private company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million. | Health Technology |